Signs of risk of obesity in newborn babies

Insights

Newborn babies with thin skinfolds and normal-weight parents may be protected from obesity. Conversely, newborns with thicker skinfolds and overweight parents face a higher risk of developing obesity later in life.

Area of Science:

  • Pediatrics
  • Genetics
  • Public Health

Background:

  • Childhood obesity is a growing public health concern with complex etiological factors.
  • Early life indicators may predict future obesity risk.
  • Parental weight status is a known correlate of offspring adiposity.

Purpose of the Study:

  • To investigate the relationship between newborn anthropometry (skinfold thickness) and parental weight status in predicting future obesity risk.
  • To identify early markers for obesity risk in infants.

Main Methods:

  • Utilized skinfold measurements in newborns to assess adiposity.
  • Categorized parental weight status (normal weight vs. overweight).
  • Correlated newborn measurements and parental factors with subsequent obesity development (postulated).

Main Results:

  • Newborns with thin skinfolds and normal-weight parents were postulated to be 'buffered against obesity'.
  • Newborns with moderate to thick skinfolds and overweight parents were identified as being at high risk for obesity.

Conclusions:

  • Newborn skinfold thickness and parental weight are potential early indicators of future obesity risk.
  • These factors may help stratify infants for targeted obesity prevention strategies.
  • Further research is needed to confirm these postulated associations and explore underlying mechanisms.

Related Concept Videos

Assessment of Airway, Skin Color, and Use of Accessory Muscles01:30

Assessment of Airway, Skin Color, and Use of Accessory Muscles

A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...